Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q1 2024 Earnings Call Transcript

Juan Jose Chacon Quiros: Yes. On that one, Josh, again, I think what we’ve said many times is that breast reconstruction is lower because you’re not really convincing just a plastic surgeon. You have to convince the plastic surgeons of a reconstructive department in a hospital and then wait for a tender to take place. So that’s why, although we see great feedback from the hospitals, who have adopted Flora and who have started to use with Flora or breast implants is still not going at the same speed of adoption that we normally see when we go into a market on purely aesthetics. However, over time, it will build, and I think it’s a big demonstration of our technology and our women’s health credentials in this industry.

Josh Jennings: Appreciate that. Thanks.

Operator: That is all the time we have for questions today. I will now turn the call back over to Juan Jose for closing remarks.

Juan Jose Chacon Quiros: Thank you for joining us on today’s call. We look forward to providing our next quarterly update in August and we wish everyone continued good health and happiness.

Operator: Thank you. This concludes today’s conference. You may disconnect your lines at this time and thank you for your participation.